At our Capital Markets Day 2022, the Executive Board will discuss the latest developments and future plans to continue our success story and journey of profitable growth.
Lipid nanoparticles (LNPs) underpin COVID-19 mRNA vaccines and are set to transform the future of medicine by delivering cutting-edge RNA therapeutics into cells.
By bringing the power of machine learning and artificial intelligence to solve medical problems, new digital health tools promise to revolutionize remote patient care.
It drives the discoveries we make and the technologies we create.
We make a positive difference to millions of people's lives every day. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices - we are everywhere.
Are you curious?